Nova Scotia court grants creditor protection to company developing cancer vaccines

The Supreme Court of Nova Scotia has issued an initial order granting protection under the Companies’ Creditors Arrangement Act to a biopharmaceutical company that develops treatments for solid and hematologic cancers, and to its...

Already a subscriber? Click here to view full article